Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Assoc Physicians India ; 68(12[Special]): 25-30, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33247660

RESUMEN

Fueled by perceptions regarding Indian dietary patterns and premixed insulin's claim to fame of providing dual fasting and post-prandial control, there was a greater inclination towards using premixed insulins in clinical practice until the last decade. However, the advent of insulin glargine 100 U/mL (Gla-100) opened up a new dimension in insulin therapy landscape in India. The data from the last 5 years reveal that Gla-100 has gained more traction among Indian clinical practitioners. Basis evidences that have emerged from various clinical studies, this present review elaborates on certain key issues which have helped Gla-100 carve its own niche and effected a progressive shift in insulin prescription pattern in India.


Asunto(s)
Diabetes Mellitus Tipo 2 , Hipoglucemia , Insulinas , Hemoglobina Glucada/análisis , Humanos , Hipoglucemiantes , India , Insulina , Insulina Glargina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA